Showing results (1131-1140 of 1,210) with videos related to

Sort By:
Pageof 121
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim TrialPeter S Hall, Alison Smith, Claire Hulme, et al.
Hepatology Communications|September 24, 2021
Cognitive Impairment and Physical Frailty in Patients With CirrhosisKacey Berry, Andres Duarte-Rojo, Joshua D Grab, et al.
The Lancet. Oncology|May 16, 2015
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trialHelena M Earl, Louise Hiller, Janet A Dunn, et al.
Breast Cancer Research : BCR|February 18, 2016
Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancerH Raza Ali, Aliakbar Dariush, Elena Provenzano, et al.
Lancet (London, England)|February 1, 2025
Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trialJanet A Dunn, Peter Donnelly, Nada Elbeltagi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis TrialH M Earl, L Hiller, J A Dunn, et al.
Inflammatory Bowel Diseases|September 4, 2020
Serum IgG4 Subclass Deficiency Defines a Distinct, Commonly Encountered, Severe Inflammatory Bowel Disease SubtypeFilippos Koutroumpakis, Anna Evans Phillips, Dhiraj Yadav, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2023
Surfaceome analysis of extracellular vesicles from senescent cells uncovers uptake repressor DPP4Qiong Meng, Chen Chen, Na Yang, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 6, 2022
Complement blockade with eculizumab for treatment of severe Coronavirus Disease 2019 in pregnancy: A case seriesRichard M Burwick, Gabriela Dellapiana, Rachel A Newman, et al.
Cancer|February 26, 2020
Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignanciesMing Fan, Jung Julie Kang, Anna Lee, et al.
Pageof 121